In contrast to the severe lethargic pathology in Mfp2−/− mice, Nestin-Mfp2−/− mice develop a milder clinical decline dominated by ataxia at a preterminal stage of disease (Verheijden et al., 2013, 2014). Here, HSD17B4 is linked to Ataxia.